Diabetes:
Indications for: GLUCAGON
Severe hypoglycemia in diabetics.
Adults and Children:
Give by IM, IV, or SC inj. Administer IM or SC inj into upper arm, thigh or buttocks. <20kg: 0.5mg or 0.02–0.03mg/kg. ≥20kg: 1mg. May repeat in 15mins as needed. After responding and able to swallow, give oral carbohydrates.
GLUCAGON Contraindications:
Pheochromocytoma. Insulinoma. Glucagonoma when used as a diagnostic test.
GLUCAGON Warnings/Precautions:
Instruct caregivers in proper use. Previously undiagnosed pheochromocytoma; risk of substantial increase in BP. If hypoglycemia develops after treatment, give oral or IV glucose. Conditions with insufficient hepatic glycogen (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Necrolytic migratory erythema (w. continuous infusion). As a diagnostic aid in diabetes or patients with cardiac disease; monitor blood glucose levels, BP, HR. Pregnancy. Nursing mothers.
GLUCAGON Classification:
Antihypoglycemic.
GLUCAGON Interactions:
Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin. Potentiates anticholinergics; avoid concomitant use (during use as a diagnostic aid). Antagonized by insulin; monitor blood glucose (during use as a diagnostic aid).
Adverse Reactions:
Inj site reactions, nausea, vomiting, headache, dizziness, asthenia, pallor, diarrhea, somnolence, decreased BP.
How Supplied:
Emergency kit (1mg)—1 (w. diluent)
Pricing for GLUCAGON
Miscellaneous diagnostic tests:
Indications for: GLUCAGON
For use during radiologic examinations to temporarily inhibit movement of the GI tract.
Adult Dosage:
To relax the stomach, duodenum, small bowel: usually 0.25–0.5mg IV or 1mg IM; up to 2mg IV or IM may be used, if needed. Stomach: 0.5mg IV or 2mg IM. Colon: 2mg IM, given approx. 10mins prior to procedure. After procedure, give oral carbohydrates to patients who have been fasting, if compatible.
Children Dosage:
Not established.
GLUCAGON Contraindications:
Pheochromocytoma. Insulinoma. Glucagonoma when used as a diagnostic test.
GLUCAGON Warnings/Precautions:
Instruct caregivers in proper use. Previously undiagnosed pheochromocytoma; risk of substantial increase in BP. If hypoglycemia develops after treatment, give oral or IV glucose. Conditions with insufficient hepatic glycogen (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Necrolytic migratory erythema (w. continuous infusion). As a diagnostic aid in diabetes or patients with cardiac disease; monitor blood glucose levels, BP, HR. Pregnancy. Nursing mothers.
GLUCAGON Classification:
Diagnostic aid.
GLUCAGON Interactions:
Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin. Potentiates anticholinergics; avoid concomitant use (during use as a diagnostic aid). Antagonized by insulin; monitor blood glucose (during use as a diagnostic aid).
Adverse Reactions:
Inj site reactions, nausea, vomiting, headache, dizziness, asthenia, pallor, diarrhea, somnolence, decreased BP.
How Supplied:
Emergency kit (1mg)—1 (w. diluent)
